financetom
Business
financetom
/
Business
/
Datadog Insider Sold Shares Worth $3,699,842, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Datadog Insider Sold Shares Worth $3,699,842, According to a Recent SEC Filing
Dec 30, 2024 1:32 PM

04:11 PM EST, 12/30/2024 (MT Newswires) -- Amit Agarwal, President, on December 26, 2024, sold 25,000 shares in Datadog ( DDOG ) for $3,699,842. Following the Form 4 filing with the SEC, Agarwal has control over a total of 203,848 shares of the company, with 195,667 shares held directly and 8,181 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1561550/000156155024000242/xslF345X05/wk-form4_1735592937.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Symbotic Delays Fiscal 2024 Annual Report, Lowers Fiscal Q1 Revenue Outlook; Shares Fall
Symbotic Delays Fiscal 2024 Annual Report, Lowers Fiscal Q1 Revenue Outlook; Shares Fall
Nov 27, 2024
07:33 AM EST, 11/27/2024 (MT Newswires) -- Symbotic ( SYM ) said Wednesday it has submitted a notification of late filing for its annual report for the fiscal year ending Sept. 28, 2024, saying it needs more time to assess and correct an error related to revenue recognition and the impact of that error on its financial reporting. The company...
Outlook Therapeutics Says Eye Disease Drug Fails Key Trial Endpoint; Shares Plunge
Outlook Therapeutics Says Eye Disease Drug Fails Key Trial Endpoint; Shares Plunge
Nov 27, 2024
07:31 AM EST, 11/27/2024 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Wednesday preliminary results from the second of two clinical trials evaluating its experimental drug, ONS-5010, an opthalmic formulation of bevacizumab in wet age-related macular degeneration patients, did not meet the pre-specified non-inferiority endpoint in the special protocol assessment with the US Food and Drug Administration. Shares of...
German cabinet approves measures for better access to capital markets
German cabinet approves measures for better access to capital markets
Nov 27, 2024
BERLIN (Reuters) - The German cabinet on Wednesday approved a package of measures to promote startups and improve access to capital markets, government sources told Reuters, though it is unclear whether it will also be green-lit by parliament before February elections. The so-called Second Financing for the Future Act is intended in particular to improve the tax framework for investments...
CrowdStrike Shares Fall 6% Despite Beating Q3 Estimates: What's Going On?
CrowdStrike Shares Fall 6% Despite Beating Q3 Estimates: What's Going On?
Nov 27, 2024
Shares of CrowdStrike Holdings Inc. ( CRWD ) dropped by 6.14% in pre-market trading on Wednesday, according to Benzinga Pro. This decline followed a weaker-than-anticipated earnings forecast for the upcoming quarter, despite the company surpassing Wall Street estimates for the third quarter. What Happened: CrowdStrike projected adjusted earnings of $0.84 to $0.86 per share for the fiscal fourth quarter, missing Wall Street’s expectation of $$0.86 cents per...
Copyright 2023-2025 - www.financetom.com All Rights Reserved